Dr. Eric Berg DC · 2026-07-10 · Eric Berg (host), Steve, Dominic
The Dr. Berg Show LIVE - July 10, 2026
46 research-tied claims examined: 6 contradicted 5 overstated 8 context 25 supported 2 unverified
5 Overstated
Diindolylmethane (DIM) derived from cruciferous vegetables acts as a natural aromatase inhibitor.
"And one natural one is is uh DIM, and it's a concentrated cruciferous uh vegetable product or you can just consume cruciferous. So that helps balance that enzyme." (said at 0:27:39)
Preclinical evidence regarding the effect of diindolylmethane (DIM) on aromatase (CYP19) is mixed and context-dependent. In vitro studies show that while DIM can downregulate aromatase expression in certain estrogen-receptor-positive breast cancer cell lines (such as MCF-7), it can upregulate or induce aromatase expression and activity in other cell types, including H295R adrenocortical cells and MDA-MB-231 cells. Furthermore, clinical trials in humans indicate that DIM primarily modulates estrogen metabolism by inducing CYP1A enzymes and shifting hydroxylation toward 2-hydroxyestrone rather than acting as a proven clinical aromatase inhibitor.
- contradicts: 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome… (Toxicological sciences : an official journal of the Society of Toxicology 2001) · cited 64x in the literature
"DIM, but not TCDD, induced aromatase activity with an apparently maximal 2-fold increase at 10 microM; higher concentrations of DIM and many of its analogs were cytotoxic. TCDD (30 nM) significantly increased CYP1A1 and 1B1 mRNA levels, but had no effect on mRNA for CYP19. DIM (3 microM) significantly increased mRNA levels for all three CYPS" (abstract, results, passage verified)
pubmedfull study (doi) - context: Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in… (Nutrition and cancer 2004) · cited 103x in the literature
"In this pilot study, DIM increased the 2-hydroxylation of estrogen urinary metabolites." (abstract, results, passage verified)
pubmedfull study (doi) - context: Modulation of CYP19 expression by cabbage juices and their active components: indole-3-car… (European journal of nutrition 2013) · cited 44x in the literature
"While cabbage juices at the lower doses diminished the aromatase expression in nontumorigenic/immortalized MCF10A breast cells (0.25-0.86-fold change, P < 0.05), I3C and DIM were more efficient in decreasing the aromatase expression in estrogen-dependant MCF7 breast cancer cells (0.24-0.82-fold change, P < 0.05). Inhibition of aromatase by juice obtained from cabbage grown on industrial farm was correlated with the induction of apoptosis (1.7-1.8-fold change, P < 0.01) in MCF10A cells. In estrogen-independent MDA-MB-231 cells, up-regulation of CYP19 expression by I3C and DIM (1.5-2.0-fold change, P < 0.05) was observed." (abstract, results, passage verified)
pubmedfull study (doi)
Postmenopausal women require at least double the premenopausal amount of dietary leucine to trigger muscle protein synthesis.
"in your diet, when you eat protein, there's some there's an amino acid called leucine. So you need to have at least double the amount of leucine that you had before menopause now just to create a signal, a message. But leucine will not work unless you open the door to uh muscle synthesis." (said at 0:43:25)
While older adults can experience age-related muscle anabolic resistance that elevates the threshold of protein and leucine required to maximally stimulate muscle protein synthesis (MPS) at rest, the claim that postmenopausal women require 'at least double' the premenopausal amount of dietary leucine is an overstatement. Evidence shows that higher per-meal protein or leucine doses (e.g., ~2.5–3 g vs. ~1.8–2 g of leucine per meal) or engaging in resistance exercise can overcome anabolic resistance, but doubling the premenopausal requirement is not supported by physiological data.
Biotin applied via shampoo cannot be absorbed through the scalp into the body.
"No, no, no. You don't absorb it, but it can help support the hair." (said at 0:57:14)
The speaker's statement bundles two assertions: that biotin applied via shampoo is not absorbed through the scalp, and that it nonetheless helps support hair. The first assertion is biologically sound: biotin is a water-soluble B vitamin, and rinse-off formulations such as shampoos provide minimal contact time and negligible transdermal penetration through the intact stratum corneum. However, the second assertion—that topical biotin in shampoo supports hair growth or hair quality—is unsupported by clinical trial evidence. Systematic reviews show that evidence for biotin improving hair health is limited to rare underlying deficiency states, with no robust clinical data supporting benefits for hair health in healthy individuals or via rinse-off topical products.
- contradicts: A Review of the Use of Biotin for Hair Loss. (Skin appendage disorders 2017) · cited 160x in the literature
"Though its use as a hair and nail growth supplement is prevalent, research demonstrating the efficacy of biotin is limited. In cases of acquired and inherited causes of biotin deficiency as well as pathologies, such as brittle nail syndrome or uncombable hair, biotin supplementation may be of benefit. However, we propose these cases are uncommon and that there is lack of sufficient evidence for supplementation in healthy individuals." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Biotin for Hair Loss: Teasing Out the Evidence. (The Journal of clinical and aesthetic dermatology 2024) · cited 2x in the literature
"Given the widespread popularity of biotin as a hair supplement, one would presume that this claim must be grounded in strong evidence; however, there is a large discrepancy between the public's perception of its efficacy and the scientific literature. The utility of biotin as a hair supplement is not supported by high-quality studies." (abstract, conclusions, passage verified)
pubmed - context: A Qualitative Review of Misinformation on Alopecia. (Skin appendage disorders 2025) · cited 2x in the literature
"Alternative unfounded therapies which were touted included mineral supplements, biotin, B vitamin complexes, fish oils, shark cartilage, onion juice, rosemary oil, horsetail extract, and saw palmetto." (abstract, results, passage verified)
pubmedfull study (doi)
Drinking hard water containing calcium and magnesium is associated with lower incidence of kidney stone formation compared to consuming softened water.
"especially as it relates to um people that consume hard water uh which has magnesium and calcium, they don't really tend to get the kidney stones as when you soften the water." (said at 0:47:00)
Epidemiological and clinical evidence evaluating the relationship between water hardness and kidney stone formation is mixed and largely inconclusive, contradicting the assertion that drinking hard water clearly prevents kidney stones compared to softened water. A 2025 prospective cohort study of 288,041 UK Biobank participants found that overall domestic water hardness and calcium concentration had no significant association with kidney stone incidence in the total population, although higher magnesium levels showed a modest protective association and hard water increased risk in certain subgroups (such as women and adults over 60). A randomized crossover trial evaluating water hardness found that consuming hard water increased urinary calcium concentration and the calcium-citrate index relative to soft water, suggesting soft water might be preferable for stone formers. While systematic reviews note that mineral content (such as magnesium and bicarbonate) can influence urinary risk parameters, there is no consistent evidence that drinking hard water prevents kidney stone formation compared to softened water.
- context: Which Type of Water Is Recommended for Patients with Stone Disease (Hard or Soft Water, Ta… (Current urology reports 2020) · cited 42x in the literature
"Studies to date have had varying results regarding the importance of hardness of water which is mostly determined by its calcium content. Other elements including magnesium and bicarbonate also play a crucial role in prevention of renal stones." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: The association between domestic water hardness and kidney stone disease: a prospective co… (International journal of surgery (London, England) 2025) · cited 19x in the literature
"In Cox regression models, higher magnesium levels (Q4, > 5 mg/L) in natural water use can reduce the risk of kidney stones [HR and 95% CI: 0.88 (0.80-0.97) in model 3], but no significant correlation was found in domestic water hardness, calcium concentration, and calcium carbonate concentration in the overall models." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Effects of water hardness on urinary risk factors for kidney stones in patients with idiop… (Nephron 1999) · cited 96x in the literature
"As compared with both tap and soft water, hard water was associated with a significant 50% increase of the urinary calcium concentration in the absence of changes of oxalate excretion; the calcium-citrate index revealed a significant threefold increase during ingestion of hard water as compared with respect to soft water (Fiuggi water), making the latter preferable even when compared with tap water." (abstract, results, passage verified)
pubmedfull study (doi)
Fasting selectively kills cancer cells because normal cells adapt to resource deprivation while cancer cells cannot.
"So if you just stop giving it resources immediately, stop eating. Your normal cells can deal with that very easily, they can adapt, but cancer cells can't. So you'll be killing a lot of cancer cells when you do fasting." (said at 1:03:54)
The speaker is describing the biological hypothesis of differential stress resistance (DSR) and differential stress sensitization (DSS), in which nutrient deprivation shifts normal cells into a protected maintenance state while oncogene-driven cancer cells cannot easily downregulate growth pathways. While this mechanism has been observed in cell culture and animal models—predominantly when evaluating fasting as an adjunct to sensitize tumors to chemotherapy—there is no robust clinical evidence demonstrating that standalone fasting effectively kills tumors or treats cancer in humans. Reviewers note that clinical trials remain preliminary and that claims of direct oncological benefit in patients are premature.
- partial: How Far Are We from Prescribing Fasting as Anticancer Medicine? (International journal of molecular sciences 2020) · cited 31x in the literature
"The rationale for this concept is that fasting elicits a differential stress response in the setting of unfavorable conditions, empowering the survival of normal cells, while killing cancer cells... There is ample nonclinical evidence indicating that fasting can mitigate the toxicity of chemotherapy and/or increase the efficacy of chemotherapy. The relevant clinical research is encouraging, albeit still in its infancy." (abstract, background and results)
pubmedfull study (doi) - contradicts: Calorie restriction in cancer patients undergoing chemotherapy: Facts, phantasy or misunde… (Clinical nutrition (Edinburgh, Scotland) 2022) · cited 6x in the literature
"Experimental studies in cancer cell lines and tumour-bearing animals support the concept that a short-period fasting could potentiate the effect of antineoplastic chemotherapy due to a particular metabolic adaptation normal cells whereas cancer cells would remain particularly sensitive to the toxic effects of the therapy. The potential of such approach is actually emphasized by the media but data in humans are very scant and many oncologists fear that peri-chemotherapy fasting might worsen the patient nutritional status... claims of oncologic benefit are premature and rumors about its efficacy are presently unjustified." (abstract, results and conclusion, passage verified)
pubmedfull study (doi) - context: Fasting and fasting mimicking diets in cancer prevention and therapy. (Trends in cancer 2023) · cited 60x in the literature
"FMD cycles increase protection in healthy cells while sensitizing cancer cells to various therapies, partly by generating complex environments that promote differential stress resistance (DSR) and differential stress sensitization (DSS), respectively." (abstract, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.